The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease

Accumulated evidence suggests that an altered ambulatory blood pressure (BP) profile, particularly elevated nighttime BP, reflects target organ injury and is a better predictor of further cardiorenal risk than the clinic BP or daytime BP in hypertensive patients complicated by chronic kidney disease...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Yanagi, Mai, Tamura, Kouichi, Fujikawa, Tetsuya, Wakui, Hiromichi, Kanaoka, Tomohiko, Ohsawa, Masato, Azushima, Kengo, Maeda, Akinobu, Kobori, Hiroyuki, Umemura, Satoshi
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3594468/
https://ncbi.nlm.nih.gov/pubmed/23154587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/hr.2012.184
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items